Simon Thompson's Alpha Reports 

Profit from a medical technology winner

Profit from a medical technology winner

 

  • This firm is strongly positioned, with a growing global market for its medical technology products.
  • Potential upside from new product launches and conservative earnings forecasts.
  • Shares look too lowly rated on cash-adjusted forward price-to-earnings ratio of 14.

 

To continue reading, subscribe to Alpha today

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now